Yellowstone Partners’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-81,634
Closed -$2.15M 218
2016
Q1
$2.15M Sell
81,634
-28,624
-26% -$2.12M 0.92% 22
2015
Q4
$11.2M Buy
110,258
+35,035
+47% +$3.94M 5.05% 2
2015
Q3
$13.4M Buy
75,223
+8,446
+13% +$1.97M 6.35% 1
2015
Q2
$14.8M Buy
66,777
+6,855
+11% +$1.52M 6.72% 1
2015
Q1
$11.9M Buy
59,922
+65
+0.1% +$11.5K 6% 1
2014
Q4
$8.57M Buy
59,857
+473
+0.8% +$63.6K 4.62% 1
2014
Q3
$7.79M Buy
59,384
+353
+0.6% +$42.1K 4.41% 3
2014
Q2
$7.45M Buy
59,031
+2,807
+5% +$358K 4.35% 2
2014
Q1
$7.41M Sell
56,224
-74
-0.1% -$10.1K 4.67% 2
2013
Q4
$6.61M Buy
+56,298
New +$6.17M 4.26% 2

Other funds holding BHC

Yellowstone Partners's BHC Position: Q2 2016 in Review

Yellowstone Partners sold out of Bausch Health (BHC) in Q2 2016, closing a stake of 81,634 shares — an estimated $2.15M sold.

Yellowstone Partners first reported a position in BHC in Q4 2013 and held it in 10 quarters. The position peaked at $14.8M in Q2 2015. 347 funds tracked by Wall St. Rank hold BHC as of Q2 2016.

  • Yellowstone Partners reported no remaining Bausch Health position as of Q2 2016 after selling out during the quarter.
  • Yellowstone Partners sold 81,634 Bausch Health shares in Q2 2016, an estimated $2.15M.
  • Yellowstone Partners first reported a position in Bausch Health in Q4 2013 and held it in 10 quarters.
  • Yellowstone Partners's Bausch Health position peaked at $14.8M in Q2 2015.
  • 347 funds tracked by Wall St. Rank held Bausch Health as of Q2 2016.

Based on Yellowstone Partners's 13F filing for Q2 2016, filed 17 Aug 2016.